BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

777 related articles for article (PubMed ID: 29609199)

  • 21. Comorbidity in psoriatic arthritis and rheumatoid arthritis.
    Sinnathurai P; Buchbinder R; Hill C; Lassere M; March L
    Intern Med J; 2018 Nov; 48(11):1360-1368. PubMed ID: 30047189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Four-year follow-up of inflammatory arthropathy patients treated with golimumab: Data from the observational multicentre NOR-DMARD study.
    Michelsen B; Sexton J; Wierød A; Bakland G; Rødevand E; Krøll F; Kvien TK
    Semin Arthritis Rheum; 2020 Feb; 50(1):12-16. PubMed ID: 31358361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eight-Year Retention Rate of First-Line Tumor Necrosis Factor Inhibitors in Spondyloarthritis: A Multicenter Retrospective Analysis.
    Favalli EG; Selmi C; Becciolini A; Biggioggero M; Ariani A; Santilli D; Fusaro E; Parisi S; Massarotti M; Marchesoni A; Meroni PL
    Arthritis Care Res (Hoboken); 2017 Jun; 69(6):867-874. PubMed ID: 27696735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis.
    Jarlborg M; Courvoisier DS; Lamacchia C; Martinez Prat L; Mahler M; Bentow C; Finckh A; Gabay C; Nissen MJ;
    Arthritis Res Ther; 2020 May; 22(1):105. PubMed ID: 32375861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rates of Cardiovascular Disease and Major Adverse Cardiovascular Events in Patients With Psoriatic Arthritis Compared to Patients Without Psoriatic Arthritis.
    Li L; Hagberg KW; Peng M; Shah K; Paris M; Jick S
    J Clin Rheumatol; 2015 Dec; 21(8):405-10. PubMed ID: 26406567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extent of axial damage in psoriatic arthritis and spondyloarthritis: comparative data from the BEPAS and (Be-)GIANT multicentre cohorts.
    de Hooge M; Ishchenko A; De Craemer AS; Steinfeld S; Nzeusseu A; Elewaut D; Lories R; de Vlam K; Van den Bosch F
    RMD Open; 2023 May; 9(2):. PubMed ID: 37137541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Golimumab in real-life settings: 2 Years drug survival and predictors of clinical outcomes in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis.
    Iannone F; Santo L; Anelli MG; Bucci R; Semeraro A; Quarta L; D'Onofrio F; Marsico A; Carlino G; Casilli O; Cacciapaglia F; Zuccaro C; Falappone PC; Cantatore FP; Muratore M; Lapadula G
    Semin Arthritis Rheum; 2017 Aug; 47(1):108-114. PubMed ID: 28216195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis.
    Cooksey R; Brophy S; Kennedy J; Gutierrez FF; Pickles T; Davies R; Piguet V; Choy E
    Semin Arthritis Rheum; 2018 Dec; 48(3):367-373. PubMed ID: 29656791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors Associated With Time to Pregnancy in Women With Axial Spondyloarthritis: A Registry-Based Multicenter Study.
    Ursin K; Lydersen S; Skomsvoll JF; Salvesen KÅ; S S Koksvik H; Jakobsen B; Wallenius M
    Arthritis Care Res (Hoboken); 2021 Aug; 73(8):1201-1209. PubMed ID: 32353185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of concomitant fibromyalgia in rheumatic diseases: Monocentric study of 691 patients.
    Fan A; Pereira B; Tournadre A; Tatar Z; Malochet-Guinamand S; Mathieu S; Couderc M; Soubrier M; Dubost JJ
    Semin Arthritis Rheum; 2017 Aug; 47(1):129-132. PubMed ID: 28216193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postpartum Depression in Reproductive-Age Women With and Without Rheumatic Disease: A Population-Based Matched Cohort Study.
    Shridharmurthy D; Lapane KL; Nunes AP; Baek J; Weisman MH; Kay J; Liu SH
    J Rheumatol; 2023 Oct; 50(10):1287-1295. PubMed ID: 37399461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project.
    Castañeda S; Martín-Martínez MA; González-Juanatey C; Llorca J; García-Yébenes MJ; Pérez-Vicente S; Sánchez-Costa JT; Díaz-Gonzalez F; González-Gay MA;
    Semin Arthritis Rheum; 2015 Jun; 44(6):618-26. PubMed ID: 26058345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents.
    Kerola AM; Rollefstad S; Kazemi A; Wibetoe G; Sexton J; Mars N; Kauppi M; Kvien TK; Haavardsholm EA; Semb AG
    Scand J Rheumatol; 2023 Jan; 52(1):42-50. PubMed ID: 35014920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular morbidity and mortality in patients with spondyloarthritis: A meta-analysis.
    Kim JH; Choi IA
    Int J Rheum Dis; 2021 Apr; 24(4):477-486. PubMed ID: 32969177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Back pain and health status in patients with clinically diagnosed ankylosing spondylitis, psoriatic arthritis and other spondyloarthritis: a cross-sectional population-based study.
    Lindström U; Bremander A; Haglund E; Bergman S; Petersson IF; Jacobsson LT
    BMC Musculoskelet Disord; 2016 Feb; 17():106. PubMed ID: 26922375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is the C-reactive protein-to-albumin ratio the most remarkable simple inflammatory marker showing active disease in patients with axial spondyloarthritis, psoriatic arthritis, and rheumatoid arthritis?
    Kaplan H; Cengiz G; Şaş S; Eldemir YÖ
    Clin Rheumatol; 2023 Nov; 42(11):2959-2969. PubMed ID: 37470884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Higher frequency but similar recurrence rate of uveitis episodes in axial spondylarthritis compared to psoriatic arthritis. A multicentre retrospective study.
    Kougkas N; Magiouf K; Gialouri CG; Evangelatos G; Pappa M; Dimouli A; Iliopoulos A; Karmanakos A; Dimitroulas T; Tektonidou MG; Sfikakis PP; Fragoulis GE
    Rheumatol Int; 2023 Nov; 43(11):2081-2088. PubMed ID: 37610650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings.
    Iannone F; Salaffi F; Fornaro M; Di Carlo M; Gentileschi S; Cantarini L; Lopalco G
    Eur J Clin Invest; 2018 Nov; 48(11):e13013. PubMed ID: 30079593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and Management of Cardiovascular Risk Factors in Psoriatic Arthritis and Rheumatoid Arthritis: A Population-Based Study.
    Jafri K; Bartels CM; Shin D; Gelfand JM; Ogdie A
    Arthritis Care Res (Hoboken); 2017 Jan; 69(1):51-57. PubMed ID: 27696731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psoriatic arthritis and spondyloarthritis assessment and management update.
    Mease P
    Curr Opin Rheumatol; 2013 May; 25(3):287-96. PubMed ID: 23492739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.